Mackenzie Financial’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-33,834
| Closed | -$967K | – | 1631 |
|
|
2025
Q4 | $967K | Sell |
33,834
-13,985
| -29% | -$266K | ﹤0.01% | 1067 |
|
|
2025
Q3 | $371K | Buy |
+47,819
| New | +$359K | ﹤0.01% | 1338 |
|
|
2025
Q1 | – | Sell |
-3,678
| Closed | -$131K | – | 1753 |
|
|
2024
Q4 | $131K | Buy |
+3,678
| New | +$190K | ﹤0.01% | 1611 |
|
|
2024
Q2 | – | Sell |
-553
| Closed | -$61.9K | – | 1594 |
|
|
2024
Q1 | $61.9K | Buy |
+553
| New | +$55K | ﹤0.01% | 1469 |
|
|
2023
Q2 | – | Sell |
-2,753
| Closed | -$283K | – | 1589 |
|
|
2023
Q1 | $283K | Sell |
2,753
-195
| -7% | -$27.4K | ﹤0.01% | 1206 |
|
|
2022
Q4 | $432K | Buy |
+2,948
| New | +$498K | ﹤0.01% | 975 |
|
|
2020
Q2 | – | Sell |
-4,231
| Closed | -$617K | – | 1090 |
|
|
2020
Q1 | $617K | Buy |
+4,231
| New | +$739K | ﹤0.01% | 771 |
|